Alexandra C.
- Country
- Spain
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 9 partner sites.
Specializations
Advanced Solid Tumor Oncology
The investigator concentrates on late‑stage malignancies that require novel systemic therapies and targeted approaches.
- Advanced Non‑Small Cell Lung Cancer
- Advanced HER2‑negative Breast Cancer
- Advanced Metastatic Melanoma
- Advanced Pancreatic Adenocarcinoma
- Advanced Renal Cell Carcinoma
These tumor types represent a core focus for therapeutic innovation within the oncology department.
Hematologic Malignancies
Research activities address both lymphoid and myeloid blood cancers, emphasizing precision medicine and immunotherapy.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Diffuse Large B‑Cell Lymphoma
- Acute Lymphoblastic Leukemia
Efforts include identifying molecular drivers and evaluating cellular‑based strategies.
Cardiovascular‑Oncology Interface
Given the overlap between cancer treatment and heart disease, the investigator explores cardioprotective strategies and vascular risk management.
- Atherosclerotic Cardiovascular Disease
- Atrial Fibrillation
- Heart Failure with Reduced Ejection Fraction
- Transthyretin Amyloid Cardiomyopathy
- Acute Coronary Syndrome
These topics support integrated care pathways for patients receiving oncologic therapies.
Immune‑Mediated and Autoimmune Disorders
The investigator’s portfolio includes several inflammatory and autoimmune conditions that often intersect with oncologic care.
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Atopic Dermatitis
- Multiple Sclerosis
Investigations aim to delineate pathogenic pathways and evaluate targeted immunomodulators.
Rare Metabolic and Genetic Diseases
Additional research attention is directed toward inherited metabolic disorders that present therapeutic challenges.
- Glycogen Storage Disease Type Ia
- Alpha‑1 Antitrypsin Deficiency
- Familial Chylomicronemia Syndrome
- Phenylketonuria
- Ornithine Transcarbamylase Deficiency
These efforts support the development of novel enzyme‑replacement and gene‑editing approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.